Bruker (BRKR) Competitors

Bruker (NASDAQ:BRKR) and Bio-Techne (NASDAQ:TECH) are both mid-cap life sciences tools & services companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Do insiders & institutionals believe in BRKR or TECH?

79.5% of Bruker shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 27.3% of Bruker shares are held by company insiders. Comparatively, 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the media refer more to BRKR or TECH?

In the previous week, Bio-Techne had 17 more articles in the media than Bruker. MarketBeat recorded 25 mentions for Bio-Techne and 8 mentions for Bruker. Bruker's average media sentiment score of 1.06 beat Bio-Techne's score of 0.68 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Techne	13 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, BRKR or TECH?

Bio-Techne has lower revenue, but higher earnings than Bruker. Bio-Techne is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.37B	1.90	$113.10M	$0.52	81.13
Bio-Techne	$1.16B	7.21	$168.10M	$0.82	64.99

Is BRKR or TECH more profitable?

Bio-Techne has a net margin of 10.89% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	2.31%	19.47%	5.95%
Bio-Techne	10.89%	13.17%	10.17%

Is BRKR or TECH a better dividend stock?

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays out 38.5% of its earnings in the form of a dividend. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has more risk and volatility, BRKR or TECH?

Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.

Do analysts prefer BRKR or TECH?

Bruker presently has a consensus price target of $52.89, indicating a potential upside of 25.36%. Bio-Techne has a consensus price target of $70.00, indicating a potential upside of 31.36%. Given Bio-Techne's stronger consensus rating and higher possible upside, analysts clearly believe Bio-Techne is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40
Bio-Techne	0 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Bio-Techne beats Bruker on 12 of the 18 factors compared between the two stocks.